Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.5.0.2
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2016
Oct. 26, 2016
Document and Entity Information    
Entity Registrant Name RIGEL PHARMACEUTICALS INC  
Entity Central Index Key 0001034842  
Document Type 10-Q  
Document Period End Date Sep. 30, 2016  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   98,937,197
Document Fiscal Year Focus 2016  
Document Fiscal Period Focus Q3